Emiliano D Baquir, NP
Nurse Practitioner · Valencia
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 8 years
- Graduated 2018
Offices
2 locations · New U Therapy Center and Family Services Inc · William Gillespie and Associates Inc
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Emiliano D Baquir’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$52,821
Medicare paid this office $52,821 for 124 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 39 | $22,533 | $84 |
| Psychotherapy with evaluation and management visit, 30 minutes | 37 | $11,876 | $48 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 35 | $6,899 | $27 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 22 | $4,257 | $52 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 21 | $1,960 | $93 |
See all 7 services
| Return visit (30+ min) | 39 | $22,533 | $84 |
| Psychotherapy with evaluation and management visit, 30 minutes | 37 | $11,876 | $48 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 35 | $6,899 | $27 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 22 | $4,257 | $52 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 21 | $1,960 | $93 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,148 | $104 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $745 | $50 |
Who their Medicare patients are
124 Original Medicare patients in 2024. Average age 74 · Under 65 20% · 85 and older 19% · Women 65% · Also on Medicaid 66% · Health risk score 2.31. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Depression 75% · Diabetes 49% · Dementia 49% · Heart failure 36% · COPD 34% · Chronic kidney disease 33% · Coronary heart disease 31% · Atrial fibrillation 27% · Cancer 20% · Stroke 18%.
The office billed $151,592, Medicare allowed $69,040 and paid $52,821; for 931 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 124 | 931 | 74 | 2.31 | $151,592 | $52,821 |
| 2023 | 89 | 693 | 70 | 1.75 | $123,485 | $41,431 |
| 2022 | 56 | 570 | 62 | 2.13 | $110,480 | $37,456 |
| 2021 | 25 | 226 | 66 | 1.12 | $47,000 | $16,035 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 34 | $20,735 | $83 |
| Psychotherapy with evaluation and management visit, 30 minutes | 34 | $11,227 | $46 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 31 | $2,747 | $28 |
| Psychiatric diagnostic evaluation with medical services | 16 | $2,006 | $125 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $1,141 | $57 |
2022: 4 services
| Return visit (30+ min) | 33 | $22,403 | $83 |
| Psychotherapy with evaluation and management visit, 30 minutes | 32 | $11,872 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,590 | $51 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,400 | $127 |
2021: 2 services
| Return visit (30+ min) | 24 | $9,439 | $92 |
| Psychotherapy with evaluation and management visit, 30 minutes | 24 | $5,179 | $50 |
Medicaid work
$53,270 in 2024
Medicaid paid $53,270 for 711 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 349 | $34,773 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 338 | $18,497 |
| SBSQ NURSING FACILITY CARE SF MDM 10 MINUTES | 24 | $0 |
| 2024 | 711 | 3 | 28 | $53,270 |
| 2023 | 612 | 2 | 27 | $41,952 |
| 2022 | 619 | 2 | 21 | $40,940 |
| 2021 | 50 | 2 | 14 | $4,074 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 320 | $29,300 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 292 | $12,653 |
2022
| Return visit (30+ min) | 328 | $28,488 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 291 | $12,452 |
2021
| Return visit (30+ min) | 36 | $3,437 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 14 | $637 |
Drugs they prescribed that Part D paid
$136,689
Pharmacies billed $136,689 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,146) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,039 generic and 107 brand-name prescriptions · $136,689 in drug cost · 91 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vraylar | 17 | $23,794 | $1,400 |
| Rexulti | 11 | $19,822 | $1,802 |
| Trintellix | 36 | $17,262 | $480 |
| Lurasidone | 15 | $10,893 | $726 |
| Vyvanse | 12 | $5,282 | $440 |
See all 36 drugs
| Vraylar | 17 | $23,794 | $1,400 |
| Rexulti | 11 | $19,822 | $1,802 |
| Trintellix | 36 | $17,262 | $480 |
| Lurasidone | 15 | $10,893 | $726 |
| Vyvanse | 12 | $5,282 | $440 |
| Xanax | 11 | $4,382 | $398 |
| Aripiprazole | 45 | $3,814 | $85 |
| Quetiapine | 40 | $1,687 | $42 |
| Atomoxetine | 25 | $1,080 | $43 |
| Buspirone | 94 | $942 | $10 |
| Oxcarbazepine | 20 | $706 | $35 |
| Dextroamphetamine-Amphetamine | 30 | $684 | $23 |
| Trazodone | 42 | $659 | $16 |
| Clonazepam | 60 | $654 | $11 |
| Lorazepam | 96 | $581 | $6 |
| Lamotrigine | 33 | $465 | $14 |
| Gabapentin | 26 | $349 | $13 |
| Zolpidem Tartrate Er | 14 | $348 | $25 |
| Fluoxetine | 36 | $344 | $10 |
| Duloxetine | 20 | $292 | $15 |
| Bupropion | 11 | $259 | $24 |
| Mirtazapine | 16 | $248 | $15 |
| Zolpidem | 52 | $248 | $5 |
| Risperidone | 24 | $237 | $10 |
| Bupropion Xl | 17 | $224 | $13 |
| Amitriptyline | 15 | $203 | $14 |
| Venlafaxine Hcl Er | 12 | $200 | $17 |
| Alprazolam | 107 | $190 | $2 |
| Olanzapine | 12 | $182 | $15 |
| Sertraline | 16 | $160 | $10 |
| Topiramate | 17 | $138 | $8 |
| Lithium Carbonate | 14 | $76 | $5 |
| Citalopram Hbr | 20 | $63 | $3 |
| Paroxetine | 11 | $25 | $2 |
| Diazepam | 12 | $24 | $2 |
| Clonidine | 11 | $24 | $2 |
Year by year
| 2024 | 1,146 | 79 | 0% (0) | 9% | $136,689 |
| 2023 | 916 | 75 | 0% (0) | 6% | $79,155 |
| 2022 | 680 | 62 | 0% (0) | 10% | $93,880 |
| 2021 | 227 | 29 | None | 9% | $11,949 |
| 2020 | 76 | 15 | 0% (0) | 14% | $12,112 |
| 2019 | 27 | None | 0% (0) | None | $8,317 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Vraylar | 11 | $16,554 | $1,505 |
| Lurasidone | 13 | $8,208 | $631 |
| Aripiprazole | 26 | $7,917 | $304 |
| Vyvanse | 12 | $4,601 | $383 |
| Quetiapine | 50 | $2,370 | $47 |
| Duloxetine | 35 | $2,292 | $65 |
| Buspirone | 80 | $1,594 | $20 |
| Atomoxetine | 13 | $1,592 | $122 |
| Trazodone | 44 | $1,198 | $27 |
| Bupropion Xl | 14 | $858 | $61 |
| Clonazepam | 66 | $767 | $12 |
| Dextroamphetamine-Amphetamine | 26 | $734 | $28 |
| Oxcarbazepine | 17 | $667 | $39 |
| Lorazepam | 42 | $553 | $13 |
| Risperidone | 24 | $518 | $22 |
| Fluoxetine | 31 | $502 | $16 |
| Gabapentin | 13 | $429 | $33 |
| Desvenlafaxine Succinate Er | 14 | $418 | $30 |
| Lamotrigine | 34 | $415 | $12 |
| Zolpidem Tartrate Er | 13 | $379 | $29 |
| Hydroxyzine | 17 | $379 | $22 |
| Citalopram Hbr | 16 | $335 | $21 |
| Zolpidem | 40 | $235 | $6 |
| Bupropion Hcl Sr | 12 | $179 | $15 |
| Diazepam | 30 | $179 | $6 |
| Clonidine | 11 | $162 | $15 |
| Sertraline | 17 | $153 | $9 |
| Alprazolam | 48 | $146 | $3 |
| Venlafaxine Hcl Er | 15 | $135 | $9 |
| Lithium Carbonate | 20 | $95 | $5 |
| Olanzapine | 11 | $79 | $7 |
2022: 23 drugs
| Vraylar | 17 | $23,572 | $1,387 |
| Latuda | 14 | $17,080 | $1,220 |
| Aripiprazole | 11 | $7,283 | $662 |
| Xanax | 13 | $5,011 | $385 |
| Duloxetine | 55 | $2,691 | $49 |
| Desvenlafaxine Succinate Er | 16 | $1,441 | $90 |
| Zolpidem | 33 | $1,170 | $35 |
| Quetiapine | 31 | $1,130 | $36 |
| Trazodone | 41 | $716 | $17 |
| Lorazepam | 60 | $566 | $9 |
| Gabapentin | 24 | $547 | $23 |
| Buspirone | 38 | $456 | $12 |
| Fluoxetine | 38 | $432 | $11 |
| Oxcarbazepine | 13 | $394 | $30 |
| Bupropion Hcl Sr | 12 | $286 | $24 |
| Hydroxyzine | 15 | $284 | $19 |
| Topiramate | 13 | $222 | $17 |
| Mirtazapine | 14 | $215 | $15 |
| Escitalopram | 15 | $146 | $10 |
| Lamotrigine | 24 | $121 | $5 |
| Clonazepam | 23 | $103 | $4 |
| Alprazolam | 30 | $59 | $2 |
| Diazepam | 11 | $30 | $3 |
2021: 6 drugs
| Xanax | 12 | $4,247 | $354 |
| Trazodone | 32 | $702 | $22 |
| Escitalopram | 24 | $376 | $16 |
| Duloxetine | 12 | $360 | $30 |
| Fluoxetine | 18 | $146 | $8 |
| Lamotrigine | 13 | $61 | $5 |
2020: 1 drug
| Trazodone | 17 | $593 | $35 |
Money from drug and device companies
$925 in 2025
| 2025 | 12 | 33 | None | $925 |
| 2024 | 11 | 25 | None | $653 |
| 2023 | 10 | 28 | None | $648 |
| 2022 | 6 | 26 | None | $534 |
| 2021 | 4 | 5 | None | $78 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tris Pharma | Dyanavel Xr | $250 | 2 payments
|
| Abbvie | Vraylar | $119 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $103 | 5 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $79 | 4 payments
|
| Otsuka America Pharmaceutical | Rexulti | $76 | 3 payments
|
| Vanda Pharmaceuticals | Fanapt | $58 | 2 payments
|
See all 33 published payments
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-17 | Trintellix | $23 |
| Neurocrine BioSciences | Meals · 2025-12-16 | Ingrezza | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-09 | Caplyta | $15 |
| Teva Pharmaceuticals USA | Meals · 2025-11-18 | Austedo Xr | $19 |
| Otsuka America Pharmaceutical | Meals · 2025-11-11 | Rexulti | $32 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-04 | Cobenfy | $33 |
| Axsome Therapeutics | Meals · 2025-10-28 | Auvelity | $18 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-21 | Caplyta | $20 |
| Abbvie | Meals · 2025-10-07 | Vraylar | $25 |
| Otsuka America Pharmaceutical | Meals · 2025-09-30 | Rexulti | $26 |
| Abbvie | Meals · 2025-08-27 | Vraylar | $15 |
| Axsome Therapeutics | Meals · 2025-08-26 | Auvelity | $33 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-19 | Trintellix | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-08-12 | Rexulti | $19 |
| Supernus Pharmaceuticals | Meals · 2025-08-04 | Qelbree | $22 |
| Abbvie | Meals · 2025-07-31 | Vraylar | $19 |
| Teva Pharmaceuticals USA | Meals · 2025-07-29 | Austedo Xr | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-22 | Cobenfy | $20 |
| Lundbeck | Meals · 2025-07-15 | Abilify Asimtufii | $15 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-01 | Caplyta | $31 |
| Vanda Pharmaceuticals | Meals · 2025-06-17 | Fanapt | $31 |
| Abbvie | Meals · 2025-06-02 | Vraylar | $26 |
| Vanda Pharmaceuticals | Meals · 2025-05-20 | Fanapt | $28 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-12 | Caplyta | $14 |
| Tris Pharma | Meals · 2025-04-22 | Dyanavel Xr | $232 |
| Supernus Pharmaceuticals | Meals · 2025-04-15 | Qelbree | $16 |
| Abbvie | Meals · 2025-04-08 | Vraylar | $17 |
| Teva Pharmaceuticals USA | Meals · 2025-03-11 | Austedo Xr | $16 |
| Tris Pharma | Meals · 2025-03-04 | Dyanavel Xr | $18 |
| Abbvie | Meals · 2025-02-25 | Vraylar | $17 |
| Lundbeck | Meals · 2025-02-04 | Rexulti | $15 |
| Teva Pharmaceuticals USA | Meals · 2025-01-28 | Austedo Xr | $18 |
| Teva Pharmaceuticals USA | Meals · 2025-01-21 | Austedo Xr | $20 |
See earlier years (2024, 2023, 2022, 2021)
2024: $653
| Janssen Pharmaceuticals | Spravato | $110 | 1 payment
|
| Abbvie | Vraylar | $110 | 5 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $81 | 3 payments
|
| Corium | Azstarys | $60 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $58 | 3 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $58 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $51 | 2 payments
|
| Lundbeck | Abilify Asimtufii | $49 | 3 payments
|
| Indivior | Perseris | $39 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $22 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $15 | 1 payment
|
2023: $648
| Abbvie | Vraylar | $271 | 12 payments
|
| Iti | Caplyta | $88 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $54 | 2 payments
|
| Alkermes | Aristada | $52 | 2 payments
|
| Indivior | Sublocade | $47 | 2 payments
|
| Lundbeck | Abilify Maintena | $45 | 2 payments
|
| Supernus Pharmaceuticals | Qelbree | $30 | 2 payments
|
| Otsuka America Pharmaceutical | Nuedexta | $23 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $20 | 1 payment
|
| Teva Pharmaceuticals USA | Uzedy | $19 | 1 payment
|
2022: $534
| Abbvie | Vraylar | $220 | 13 payments
|
| Iti | Caplyta | $167 | 6 payments
|
| Supernus Pharmaceuticals | Qelbree | $52 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $48 | 2 payments
|
| Indivior | Perseris | $29 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $18 | 1 payment
|
2021: $78
| Alkermes | Aristada | $34 | 2 payments
|
| Lundbeck | Rexulti | $16 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Maintena | $16 | 1 payment
|
| AbbVie | Vraylar | $13 | 1 payment
|
Professional record
- NPI
- 1861951352
- Licence
- CA NP95010889
- Group
- New U Therapy Center and Family Services Inc · William Gillespie and Associates Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 2018 Jolley Dr, Burbank, CA, 91504
- NPI first listed
- 2019-03-14
- NPI last updated
- 2021-10-12
- NPI record certified
- 2021-10-12
This is when the NPI record was last certified, not a medical board exam.